Trials / Completed
CompletedNCT04005586
A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)
A Prospective Controlled Multi-Center Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- RxSight, Inc. · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety and effectiveness of performing 0.50 D cylinder correction on the RxSight Light Adjustable Lens (LAL) in patients who have undergone implantation with the FDA approved, commercially available LAL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Light Delivery Device (LDD) | Study eye will undergo Light delivery Device treatments |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2019-07-02
- Last updated
- 2021-06-11
- Results posted
- 2021-06-11
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04005586. Inclusion in this directory is not an endorsement.